Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Capital Expenditures (2016 - 2025)

National Research (NRC) has disclosed Capital Expenditures for 16 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures fell 74.77% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.7 million through Dec 2025, down 30.7% year-over-year, with the annual reading at $10.7 million for FY2025, 30.7% down from the prior year.
  • Capital Expenditures hit $1.1 million in Q4 2025 for National Research, down from $3.6 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $5.3 million in Q2 2024 to a low of -$6.8 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $2.4 million across 5 years, with a median of $2.9 million in 2022.
  • Biggest YoY gain for Capital Expenditures was 301.51% in 2022; the steepest drop was 493.71% in 2022.
  • Year by year, Capital Expenditures stood at $1.7 million in 2021, then plummeted by 493.71% to -$6.8 million in 2022, then soared by 155.77% to $3.8 million in 2023, then rose by 17.88% to $4.4 million in 2024, then plummeted by 74.77% to $1.1 million in 2025.
  • Business Quant data shows Capital Expenditures for NRC at $1.1 million in Q4 2025, $3.6 million in Q3 2025, and $3.9 million in Q2 2025.